Clinical Trial Update: A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating HMPL-306 in IDH1- or IDH2-mutated acute myeloid leukemia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• HMPL-306

Snippet

Sponsor: Hutchmed | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING